Galderma Group N (GALD) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.08x

Galderma Group N (GALD) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting CHF37.07 Million (capex CHF37.07 Million ) from operating cash flow of CHF475.06 Million. Check GALD cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.08x
(Capex + Investments) / Operating CF

Total Reinvested

CHF37.07 Million
Capex + Investments

Operating Cash Flow

CHF475.06 Million
CHF

Capital Expenditures

CHF37.07 Million
CHF

Galderma Group N Cash Flow Reinvestment Rate (2021–2024)

Historical reinvestment intensity for Galderma Group N across 4 annual periods. Explore GALD operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Galderma Group N (2021–2024)

Year-by-year capital reinvestment analysis for Galderma Group N. For live market cap and broader valuation context, see Galderma Group N (GALD) market capitalisation.

Year Reinvestment Rate Total Reinvested (CHF) Operating CF Capex YoY Change
2024 0.64x CHF275.00 Million CHF429.77 Million CHF275.00 Million ▼ -6.8%
2023 0.69x CHF102.02 Million CHF148.64 Million CHF102.02 Million ▼ -52.1%
2022 1.43x CHF152.33 Million CHF106.30 Million CHF152.33 Million ▲ +119.1%
2021 0.65x CHF117.03 Million CHF178.92 Million CHF117.03 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow